- Home
- NGNE vs JPI Comparison
NGNE vs JPI Comparison
Compare NGNE & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- JPI
- Stock Information
- Founded
- NGNE 2003
- JPI 2012
- Country
- NGNE United States
- JPI United States
- Employees
- NGNE N/A
- JPI N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- JPI Finance Companies
- Sector
- NGNE Health Care
- JPI Finance
- Exchange
- NGNE Nasdaq
- JPI Nasdaq
- Market Cap
- NGNE 471.1M
- JPI 482.8M
- IPO Year
- NGNE N/A
- JPI N/A
- Fundamental
- Price
- NGNE $15.59
- JPI $20.21
- Analyst Decision
- NGNE Strong Buy
- JPI
- Analyst Count
- NGNE 6
- JPI 0
- Target Price
- NGNE $60.80
- JPI N/A
- AVG Volume (30 Days)
- NGNE 539.5K
- JPI 54.7K
- Earning Date
- NGNE 11-18-2024
- JPI 01-01-0001
- Dividend Yield
- NGNE N/A
- JPI 6.15%
- EPS Growth
- NGNE N/A
- JPI N/A
- EPS
- NGNE N/A
- JPI N/A
- Revenue
- NGNE $925,000.00
- JPI N/A
- Revenue This Year
- NGNE N/A
- JPI N/A
- Revenue Next Year
- NGNE N/A
- JPI N/A
- P/E Ratio
- NGNE N/A
- JPI N/A
- Revenue Growth
- NGNE N/A
- JPI N/A
- 52 Week Low
- NGNE $12.49
- JPI $16.02
- 52 Week High
- NGNE $74.49
- JPI $19.12
- Technical
- Relative Strength Index (RSI)
- NGNE 26.51
- JPI 34.13
- Support Level
- NGNE $35.60
- JPI $19.86
- Resistance Level
- NGNE $43.24
- JPI $20.59
- Average True Range (ATR)
- NGNE 6.30
- JPI 0.34
- MACD
- NGNE -5.15
- JPI -0.10
- Stochastic Oscillator
- NGNE 1.85
- JPI 23.81
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.